The differential effect of apoferritin-PbS nanocomposites on cell cycle progression in normal and cancerous cells
Version 2 2024-03-12, 14:14Version 2 2024-03-12, 14:14
Version 1 2024-03-01, 09:35Version 1 2024-03-01, 09:35
journal contribution
posted on 2024-03-12, 14:14 authored by Lyudmila Turyanska, T. D. Bradshaw, M. Li, P. Bardelang, W. C. Drewe, M. W. Fay, S. Mann, A. Patane, N. R. Thomas<p>We report the effects induced by near-infrared apoferritin-PbS (AFt-PbS) nanocomposites on cell cycle progression in non-tumorigenic and cancerous human cells. By using flow cytometry and Annexin V assay, we show that the cell cycle of non-tumorigenic cells is not altered by exposure to AFt-PbS nanoparticles at concentrations up to 1 mg mL -1. In contrast, exposure of human-derived breast cancer cell lines to AFt-PbS at concentrations > 0.2 mg mL -1 triggers apoptotic cell death. The selective death of cancerous cells and the near-infrared fluorescence properties of AFt-PbS could be exploited in both nanomedicine and in vivo imaging studies. © 2012 The Royal Society of Chemistry.</p>
History
School affiliated with
- School of Chemistry (Research Outputs)
Publication Title
Journal of Materials ChemistryVolume
22Issue
2Pages/Article Number
660-665Publisher
Royal Society of ChemistryExternal DOI
ISSN
0959-9428eISSN
1364-5501Date Submitted
2016-03-27Date Accepted
2011-10-19Date of First Publication
2011-11-07Date of Final Publication
2012-01-14Date Document First Uploaded
2016-03-21ePrints ID
22518Usage metrics
Categories
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC


